Reduced quality of life and greater psychological distress in vasovagal syncope patients compared to healthy individuals
- PMID: 30488466
- PMCID: PMC6358504
- DOI: 10.1111/pace.13559
Reduced quality of life and greater psychological distress in vasovagal syncope patients compared to healthy individuals
Abstract
Background: Vasovagal syncope (VVS) patients have a reduced health-related quality of life (HRQoL). There are limited data comparing HRQoL and psychological profile in VVS patients and healthy individuals. We tested the hypothesis that VVS patients have greater impairment in both HRQoL and psychological profile compared to healthy nonfainting individuals, and that both outcome measures are negatively correlated for VVS patients.
Methods: The RAND 36-Item Health Survey (RAND36), global health visual analogue scale (VAS), Hospital Anxiety and Depression Scale, Anxiety Sensitivity Index, and Positive and Negative Affect Schedule - Expanded Form were completed by healthy individuals and at baseline by VVS patients enrolled in the Second Prevention of Syncope Trial, a randomized, placebo-controlled trial of fludrocortisone for VVS.
Results: Data were available on 76 VVS patients (34 ± 14 years; 68% F) and 85 healthy participants (35 ± 11 years; 80% F). Compared to healthy participants, VVS patients reported poorer HRQoL on all scales of the RAND36 and the VAS. VVS patients had significantly greater anxiety, depression, and anxiety sensitivity (each P < 0.001). VVS patients had more negative affect (P < 0.001) and less positive affect (P = 0.003) compared to healthy participants. Anxiety, depression, and anxiety sensitivity were negatively correlated with HRQoL for VVS patients, but not for healthy participants.
Conclusion: In this first direct comparison, VVS patients have a significantly reduced HRQoL and more anxiety and depression compared to healthy nonfainting individuals. For VVS patients, there is a relationship between psychological distress and HRQoL, suggesting a potential benefit from more comprehensive assessment and treatment.
Keywords: anxiety; depression; quality of life; vasovagal syncope.
© 2018 Wiley Periodicals, Inc.
Conflict of interest statement
DISCLOSURES
SRR is a consultant for Lundbeck NA Ltd., GE Healthcare, Abbott Laboratories, and Boston Scientific Corporation. Other authors have no conflicts to declare.
Figures
References
-
- Ganzeboom KS, Mairuhu G, Reitsma JB, Linzer M, Wieling W and van Dijk N. Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35–60 years. J Cardiovasc Electrophysiol. 2006;17:1172–6. - PubMed
-
- Sheldon RS, Grubb BP 2nd, Olshansky B, Shen WK, Calkins H, Brignole M, Raj SR, Krahn AD, Morillo CA, Stewart JM, Sutton R, Sandroni P, Friday KJ, Hachul DT, Cohen MI, Lau DH, Mayuga KA, Moak JP, Sandhu RK and Kanjwal K. 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015;12:e41–63. - PMC - PubMed
-
- Rose MS, Koshman ML, Spreng S and Sheldon R. The relationship between health–related quality of life and frequency of spells in patients with syncope. J Clin Epidemiol. 2000;53:1209–16. - PubMed
-
- Gracie J, Newton JL, Norton M, Baker C and Freeston M. The role of psychological factors in response to treatment in neurocardiogenic (vasovagal) syncope. Europace. 2006;8:636–43. - PubMed
-
- Cohen TJ, Thayapran N, Ibrahim B, Quan C, Quan W and von zur Muhlen F. An association between anxiety and neurocardiogenic syncope during head–up tilt table testing. Pacing Clin Electrophysiol. 2000;23:837–41. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
